Home / Letter From The Editor / Dec. 1, 2018

Dec. 1, 2018

Dec 1, 2018
 

For the last two years, my wife has been controlling her diabetes with long-acting insulin, a GLP-1 analog, and an SGLT-2 Inhibitor. After she was diagnosed two and a half years ago, she lost over 80 lbs and her A1c went from 13.7 to 7.2. Over the past four months, she had seen her SMBG readings increase by 40 to 50 mg/dl, even though she was still watching her carbs, increasing her long-acting insulin and riding her bike 12 to 15 miles a day.

A recent bout with mild food poisoning sent her to the hospital with severe nausea and vomiting, dehydration and, you guessed it, DKA. After three days in the hospital, she was discharged and we started her on mealtime insulin with a correction factor and carb ratio.

At first, she felt like her condition was getting worse because of the addition of the mealtime insulin, but after we discussed it, she realized that she actually had more control over her health and that this would likely be a better method for care.

This kind of thinking goes along with a study of over 1,600 patients in the Fremantle Diabetes Study Phase 2, looking at the patient perception of health and quality of life issues. Click here to see how their findings correlate with my wife’s opinion.

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief